RecruitingNot ApplicableNCT06088420

Analgesic Efficacy of Different Nerve Blocks in Postoperative Cesarean Section

Analgesic Efficacy of Erector Spinae Block , Quadratus Lumborum Block, and Intrathecal Morphine for Postoperative Pain Relief After Cesarean Section: A Randomized Study


Sponsor

Assiut University

Enrollment

120 participants

Start Date

Oct 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

comparing analgesic efficacy of different nerve blocks on post operative cesarean sections.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria4

  • -40 years old
  • more or equal 37 weeks of gestation
  • ASA 1,2
  • Elective cesarean delivery

Exclusion Criteria10

  • Patient refusal
  • inability to cooperate with or understand the study
  • local infection.
  • bleeding disorder
  • known anaphylaxis to any drug used in the trial
  • ASA physical status more than 2
  • emergency operations
  • chronic opioid use (opioid use in the past 3 months)
  • Neurologic deficit or disorder
  • contraindication to regional anesthesia.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREIntrathcal Morphine Group

intrathecal morphine (150 μg) in addition to standard spinal anesthetic drugs(10-12 mg 0.5% hyperbaric bupivacaine)

PROCEDUREQuadratus Lumborum nerve block(QL) group

intrathecal morphine (150 μg) in addition to standard spinal anesthetic drugs (10-12 mg 0.5% hyperbaric bupivacaine) + bilateral QL block by injecting 20 ml of 0.25% isobaric bupivacaine bolus with 4 mg ) dexamethasone as an adjuvant

PROCEDUREErector Spinae nerve block (ESP)group

intrathecal morphine (150 μg) in addition to standard spinal anesthetic drugs (10-12 mg 0.5% hyperbaric bupivacaine) + bilateral ESP block by injecting 20 ml of 0.25% isobaric bupivacaine bolus with 4 mg ) dexamethasone as an adjuvant


Locations(1)

Mahmoud Mamdouh Ekram

Asyut, Manfalout, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06088420


Related Trials